Clinical Stage III Nodal or Intransit Disease or Resectable Stage IV Melanoma
1 clinical trials · Condition
◉ Watch Clinical Stage III Nodal or Intransit Disease or Resectable Stage IV Melanoma
| Record | Firm | Date |
|---|---|---|
| Early FDG PET in Melanoma (NCT02716077) | Abramson Cancer Center at Penn Medicine | 2016-03-01 |
Track Clinical Stage III Nodal or Intransit Disease or Resectable Stage IV Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.